C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2006
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	CN1852894A Crystalline forms of [R-(r,r)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
10/25/2006	CN1852893A (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
10/25/2006	CN1850799A 1-phenyl 2-trifluoromethyl-tetrahydro pyrrole and its synthesizing method
10/25/2006	CN1850779A Beta-element nitrogenous derivative, and its preparing method and use
10/25/2006	CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/24/2006	US7126028 Process for preparing chiral compounds
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7126007 Reproducible; avoids use of 3-pyrrolidinol as a starting material
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125442 Lightfast additive having UV-absorbing moiety and ink composition including the same
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2262451C Boronic compound complexing reagents and complexes
10/24/2006	CA2261848C Cell adhesion inhibitors
10/19/2006	WO2006110918A1 Pyrrole compounds and uses thereof
10/19/2006	WO2006110783A2 Process for making (s)-pregabalin
10/19/2006	WO2006110668A1 Compounds which inhibit beta-secretase activity and methods of use thereof
10/19/2006	WO2006109869A1 Production method of n-vinyl-2-pyrrolidone
10/19/2006	WO2006109323A1 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
10/19/2006	WO2006108693A2 Process for preparing bicyclic compounds
10/19/2006	WO2006108689A2 Process for preparing bicyclic compounds
10/19/2006	WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006	WO2006108224A1 Antiparasitic compounds
10/19/2006	WO2006096810A3 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0] hexanes
10/19/2006	WO2006090265A3 Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions
10/19/2006	WO2006081562A3 Synthesis of aryl pyrrolidones
10/19/2006	WO2006064336A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/19/2006	WO2005087700A3 Bisphenyl compounds useful as vitamin d3 receptor agonists
10/19/2006	US20060235220 Dipeptide nitriles
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders
10/19/2006	US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators
10/19/2006	US20060235003 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
10/19/2006	CA2604397A1 Process for preparing bicyclic compounds
10/19/2006	CA2604388A1 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
10/19/2006	CA2604384A1 Process for preparing bicyclic compounds
10/19/2006	CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof
10/19/2006	CA2603215A1 Process for making (s)-pregabalin
10/19/2006	CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/18/2006	EP1712554A1 Pyridobenzoxazine derivative
10/18/2006	EP1712547A1 Bicycloester derivative
10/18/2006	EP1711809A2 Time-temperature indicator based on valence isomerizations
10/18/2006	EP1711805A2 Detection cartridges, modules, systems and methods
10/18/2006	EP1711489A1 Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid
10/18/2006	EP1711464A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation
10/18/2006	EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/18/2006	EP1711462A1 Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
10/18/2006	EP1711175A1 Diurea derivatives
10/18/2006	EP1641753B1 Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate
10/18/2006	CN1849308A Thiophenylaminoimidazolines
10/18/2006	CN1849303A Novel heteroaryl derivative
10/18/2006	CN1849117A Entry inhibitors of the HIV virus
10/18/2006	CN1846696A Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/18/2006	CN1280271C Arylphenyl-substituted cyclic keto-enols
10/18/2006	CN1280270C Production process of pyrrolidone carboxylic acid and its salt
10/18/2006	CN1280269C Aliphatic nitrogenous five-membered ring compounds
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/17/2006	US7122683 2,3-dichloro-N-cyclopentyl-N-[(3S) -pyrrolidin-3-yl]benzamide; both serotonin and oradrenaline re-uptake inhibitors; urinary incontinence, pain, depression
10/17/2006	US7122682 Chemical intermediates used for manufacturing (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidine acetamide which is used in therapy and prophylaxis epilepsy and other neurological disorders
10/17/2006	US7122681 Displacement of solvent by vapor diffusion of water
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122675 Gamma secretase inhibitors
10/17/2006	US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122562 Amine oxidase inhibitor; use in treatment of Alzheimer's disease and senile dementia
10/17/2006	US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006	US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006	US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/17/2006	US7122189 Releasable polymeric conjugates based on aliphatic biodegradable linkers
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/12/2006	WO2006107661A1 Histamine h3 receptor agents, preparation and therapeutic uses
10/12/2006	WO2006107175A1 Beta-sulfone imides and preparation thereof
10/12/2006	WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006	WO2006106372A1 New crystalline atorvastatin hemicalcium salt polymorph form
10/12/2006	WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/12/2006	WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/12/2006	WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
10/12/2006	US20060229449 Reacting with chloramine in presence of aqueous base, phase transfer catalyst; anti-cancer agents, kinase inhibitors
10/12/2006	US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease
10/12/2006	US20060229353 Substituted heterocycles
10/12/2006	US20060229343 Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
10/12/2006	US20060229286 Therapy of diabetes
10/12/2006	US20060229254 Compounds having prolyl oligopeptidase inhibitory activity
10/12/2006	CA2603398A1 Sulfonylpyrroles as histone deacetylase inhibitors
10/12/2006	CA2602467A1 Bcrp/abcg2 inhibitor
10/12/2006	CA2602234A1 Histamine h3 receptor agents, preparation and therapeutic uses
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1710234A1 Malononitrile compound and use thereof
10/11/2006	EP1710231A1 CETP activity inhibitors
10/11/2006	EP1709963A2 Use of amtolmetin guacyl for the production of a drug for counteracting blood platelet aggregation
10/11/2006	EP1709004A2 Pyrrole and pyrazole daao inhibitors
10/11/2006	EP1708995A1 Aspartates useful as components in coating compositions and their preparation
10/11/2006	EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006	EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006	CN1845934A Process for the manufacture of an enantiopure compound
10/11/2006	CN1845925A Substituted heterocycles
10/11/2006	CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors
10/11/2006	CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use
10/10/2006	US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders

1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 404